AKT1 and cancer: The three RAS isoforms (NRAS, KRAS, and HRAS) are frequently mutated in cancer and constitutively activate intracellular signaling through a variety of pathways (mainly the MAPK and PI3K/Akt pathways) inducing cell-cycle dysregulation, pro-survival behavior, and cellular proliferation [8].